ETFs
A
ACAD
Acadia Pharmaceuticals Inc
22.20
-0.12-0.54%After Hours: 22.20 0.00 0.00%16:10 04/02 EDT
OPEN/PREV CLOSE21.85/22.32
TODAY RANGE21.72-22.49
VOL1.70M
MARKET CAP3.78B
52 WEEK RANGE13.40-28.35
AVG VOL (3M)1.68M
% TURNOVER1.00%
TURNOVER--
P/E (TTM)9.65
% RANGE3.38%
EPS(TTM)2.301
P/E(FORWARD)49.33
P/B3.080
BVPS7.21
DIVIDEND--
P/S3.529
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.73B
SHARES OUTSTANDING170.49M
NEXT EARNINGS05/05-05/11
FREE FLOAT168.19M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Biotech Is Holding Steady In 2026
Seeking Alpha·2d ago
Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports
NASDAQ·03/27 15:30
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Simply Wall St·03/27 03:08
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Mixed Share Performance
Benzinga·03/25 19:43
This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Seeking Alpha·03/25 15:51
Acadia Pharma upgraded at BofA following stock pullback
TipRanks·03/25 13:50
Arm upgraded, Mondelez downgraded: Wall Street’s top analyst calls
Dow Jones·03/25 12:54
ACADIA Pharmaceuticals Raised to Buy From Neutral by B of A Securities
TipRanks·03/25 10:20
Acadia Pharmaceuticals upgraded to Buy at BofA following 25% pullback
TipRanks·03/25 10:11
Acadia Pharmaceuticals upgraded to Buy from Neutral at BofA
Reuters·03/25 08:01
U.S. RESEARCH ROUNDUP-Amazon, Diamondback Energy, Matador Resources
TipRanks·03/24 11:06
RBC Capital Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD)
Same Industry
Name/Symbol
Change%
Price